AXGN: axogeninc.com Growth-Adjusted Market Cap to Net Income

Symbol and logo of brand axogeninc.com (AXGN)

Despite its dependence on insurance reimbursements and FDA certification complexities, AxoGen, Inc. (AXGN) demonstrates resilience to economic downturns due to stable demand for neurosurgery. The ratio of cost to business expansion rates on the GURU.Markets daily chart shows that the 1.44 metric serves as a target level. The increasing number of procedures using Avance matrices is currently creating strong momentum for the company's development.

AxoGen, Inc. (AXGN) - PEG Multiple from 07/04/2022 to 11/10/2026

AxoGen, Inc. (AXGN) - metric breakdowns and financial figures

- current price and projected stock value:
Price Chart AxoGen Inc|AXGN - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Axogen Corp|AXGN - Real Price to Acquire Entire Company
- company book value details:
Share Book Value Axogen|AXGN - Book Capitalization|Market-to-Book Ratio axogeninc.com|AXGN - Company Total Assets
- business debt structure and liquidity details:
Debt to Equity Ratio AxoGen, Inc.|AXGN - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital axogeninc.com|AXGN - Company Debts|Debt to Book Value Axogen Corp|AXGN - Company Long-Term Debts|Short-Term Debt Axogen|Immediate Liquidity Ratio axogeninc.com
- earnings and valuation multiples indicators:
AXGN - Net Profit|Company Profit Forecast AxoGen, Inc.|AXGN - P/E Multiple|Projected Price to Earnings Axogen Surgical|AXGN - PEG Multiple|EV/EBITDA Multiple Axogen Corp|AXGN - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Axogen|AXGN - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months axogeninc.com|AXGN - Earnings growth in current year|Expected net earnings per share growth next year AxoGen, Inc.
Fundamental company analysis:AXGN (AxoGen Inc)
Manufactured products of axogeninc.com

For nerve regeneration leader AxoGen, Inc. (AXGN), the PEG ratio serves as a tool to benchmark market valuation against the earnings growth driven by the adoption of Avance grafts. This metric divides the P/E ratio by the earnings growth rate: values below one on the chart signal that the business is undervalued, allowing investors to identify potential for rapid capital appreciation provided there are no hidden financial gaps.

Competing companies

Price/Earnings to Growth Ratio BSX (Boston Scientific Corp)|PEG Multiple EW (Edwards Lifesciences Corp)|Growth-Adjusted Market Cap to Net Income ResMed Corporation (RMD)|PODD: Price/Earnings to Growth Multiple|Market Cap to Earnings and Growth Ratio ZBH|COO: PEG Multiple|Price to Earnings Adjusted for Growth Rate Invisalign (ALGN)|GMED (Globus Medical Corp) - PEG Multiple|Growth-Adjusted P/E Ratio TMDX (transmedics.com)|Price/Earnings to Growth Multiple ATEC (Alphatec Holdings, Inc.)|AORT (artivion.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Enovis ENOV|IART - Price/Earnings to Growth Multiple|Motiva - PEG Multiple|Price to Earnings Adjusted for Growth Rate iLet Bionic Pancreas|IRMD: PEG Multiple|Growth-Adjusted P/E Ratio EMBC|TNDM (Tandem Diabetes Care, Inc.) - PEG Multiple|SI-BONE Inc (SIBN) - Growth-Adjusted Market Cap to Net Income|PEG Multiple OFIX|Price/Earnings to Growth Multiple Bioventus Global BVS|PEG Multiple KIDS (OrthoPediatrics)|PEG Multiple treace.com TMCI|SRTA - Price/Earnings to Growth Ratio|CARL: Price/Earnings to Growth Ratio|RXST (RxSight Corp) - Price/Earnings to Growth Multiple|ClearPoint Neuro - Growth-Adjusted Payback Ratio|STXS (Stereotaxis, Inc.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate neurostar.com STIM|Price/Earnings to Growth Ratio Sight Sciences (SGHT)|Orchestra BioMed Inc. (OBIO) - Price to Net Income Growth Ratio|Anika Therapeutics, Inc. - Price/Earnings to Growth Multiple|PEG Multiple InspireMD Inc. NSPR|Jin Medical International Ltd - PEG Multiple|Growth-Adjusted Market Cap to Net Income Vivani Medical, Inc. VANI|xtantmedical.com (XTNT) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio NMTC (NeuroOne)|Price/Earnings to Growth Ratio Modular Medical Inc|Price/Earnings to Growth Multiple Myomo Inc (MYO)|PEG Multiple COCH|VVOS - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio enVVeno Medical Corp. NVNO|SINT: Growth-Adjusted P/E Ratio|TNON: Price/Earnings to Growth Multiple|Lifeward Ltd. - Company Value to Earnings Growth Ratio|AMIX: PEG Multiple|invobioscience.com (IVF) - PEG Multiple|Price/Earnings to Growth Multiple BBLG|Growth-Adjusted P/E Ratio AXNX (Axonics Inc.)|Price/Earnings to Growth Ratio Biolase, Inc. (BIOL)|DYNT - Price to Earnings Adjusted for Growth Rate|PEG Multiple FNA (Paragon 28)|Price to Net Income Growth Ratio INVO Bioscience Inc.